Pfizer warns health care professionals of possible carcinogen in Viracept.
D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002273:Carcinogens / Q000633:toxicity; D002461:Cell Line, Transformed; D004345:Drug Industry; D006801:Humans; D019888:Nelfinavir / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use
D019380:Anti-HIV Agents; D002273:Carcinogens; D019888:Nelfinavir